CorFlow Therapeutics is a Switzerland-based developer of a novel diagnostic and drug delivery medical device designed to diagnose and address microvascular disease, specifically microvascular obstruction (MVO), in patients suffering from heart attack. Known as the CoFITM System, the device could improve the treatment of heart attack patients with MVO in the future, improving their therapeutic outcomes.
read more..